MBA, Chief Science Officer & Co-Founder, Panaceutics
As Co-founder and CSO, Staton uses his 25 years of experience in biotechnology and pharmaceutical research to help create products for an individual’s health and wellness needs. Staton holds a BS in Biochemistry, MS in Gerontology, and an MBA, and has authored multiple peer-reviewed scientific papers. As a molecular pharmacologist at GlaxoSmithKline, Staton developed broad technical expertise and therapeutic expertise while leading multiple drug discovery projects. In addition, Staton spent five years as Director of the Office of Innovation Commercialization at UNC-Greensboro managing and licensing intellectual property, and negotiating complex inter-institutional agreements.
Wellness and Aging Showcase: Panaceutics
Panaceutics Inc. has built a scalable software and robotic automation system designed to manufacture personalized/ precision drug and wellness formulations on demand.
On Demand Manufacturing For Personalized Formulations
For personalized medicine to reach its potential to treat individuals more effectively than current practices, not only is selection of the right drug and right doses critical, but also the right combination of drugs. Panaceutics, Inc has built a patented automated-on demand manufacturing platform to produce personalized combinatorial formulations based on an individual’s needs. This platform could help decrease the pill burden and improve adherence for many chronic diseases and long term wellness therapies.